Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board

VANCOUVER, British Columbia, April 13, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE:…

Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea

VANCOUVER, British Columbia, April 09, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial

VANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…